These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 24077830)

  • 1. Circulating miRNAs: a new generation of anti-doping biomarkers.
    Leuenberger N; Robinson N; Saugy M
    Anal Bioanal Chem; 2013 Dec; 405(30):9617-23. PubMed ID: 24077830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs: The Future of Biomarkers in Anti-doping Field.
    Leuenberger N; Saugy M
    Adv Exp Med Biol; 2015; 888():401-8. PubMed ID: 26663194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker monitoring in sports doping control.
    Pottgiesser T; Schumacher YO
    Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current strategies of blood doping detection.
    Pottgiesser T; Schumacher YO
    Anal Bioanal Chem; 2013 Dec; 405(30):9625-39. PubMed ID: 23934350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA-122 as Potential Biomarker for Detection of Testosterone Abuse.
    Salamin O; Jaggi L; Baume N; Robinson N; Saugy M; Leuenberger N
    PLoS One; 2016; 11(5):e0155248. PubMed ID: 27171140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current implementation and future of the Athlete Biological Passport.
    Sottas PE; Vernec A
    Bioanalysis; 2012 Jul; 4(13):1645-52. PubMed ID: 22831480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of the biological passport: the experience of the International Cycling Union.
    Zorzoli M; Rossi F
    Drug Test Anal; 2010; 2(11-12):542-7. PubMed ID: 21204287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analytical challenges of anti-doping analysis.
    Harrison CR
    Anal Bioanal Chem; 2013 Dec; 405(30):9615-6. PubMed ID: 24043378
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating microRNAs as long-term biomarkers for the detection of erythropoiesis-stimulating agent abuse.
    Leuenberger N; Jan N; Pradervand S; Robinson N; Saugy M
    Drug Test Anal; 2011; 3(11-12):771-6. PubMed ID: 22113880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.
    Zen K; Zhang CY
    Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of biological markers indicative of doping: the athlete biological passport.
    Saugy M; Lundby C; Robinson N
    Br J Sports Med; 2014 May; 48(10):827-32. PubMed ID: 24659506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Athlete Biological Passport: How to Personalize Anti-Doping Testing across an Athlete's Career?
    Robinson N; Sottas PE; Schumacher YO
    Med Sport Sci; 2017; 62():107-118. PubMed ID: 28578329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in doping testing for erythropoietin.
    Reichel C
    Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and perspectives in anti-doping testing.
    Schamasch P; Rabin O
    Bioanalysis; 2012 Jul; 4(13):1691-701. PubMed ID: 22831484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of RNA biomarkers in the antidoping field.
    Loria F; Grabherr S; Kuuranne T; Leuenberger N
    Bioanalysis; 2024; 16(10):475-484. PubMed ID: 38497758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical challenges in the detection of peptide hormones for anti-doping purposes.
    Barroso O; Handelsman DJ; Strasburger C; Thevis M
    Bioanalysis; 2012 Jul; 4(13):1577-90. PubMed ID: 22831474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Doping - hormonal preparations are always being refined].
    Sportverletz Sportschaden; 2012 Sep; 26(3):136-7. PubMed ID: 23042043
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating microRNA as a biomarker of human growth hormone administration to patients.
    Kelly BN; Haverstick DM; Lee JK; Thorner MO; Vance ML; Xin W; Bruns DE
    Drug Test Anal; 2014 Mar; 6(3):234-8. PubMed ID: 23495241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OMICS-strategies and methods in the fight against doping.
    Reichel C
    Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.